Log in to save to my catalogue

Clinical outcome and molecular landscape of patients with ARID1A‐loss gastric cancer

Clinical outcome and molecular landscape of patients with ARID1A‐loss gastric cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2906772169

Clinical outcome and molecular landscape of patients with ARID1A‐loss gastric cancer

About this item

Full title

Clinical outcome and molecular landscape of patients with ARID1A‐loss gastric cancer

Publisher

England: John Wiley & Sons, Inc

Journal title

Cancer science, 2024-03, Vol.115 (3), p.905-915

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Chromatin remodelers are commonly altered in human cancer. The mutation of AT‐rich interactive domain 1A (ARID1A) in gastric cancer (GC), a component of the SWI/SNF chromatin remodeling complex, was proven associated with treatment response in our previous study. However, ARID1A loss of function was caused not only by mutations but also copy number...

Alternative Titles

Full title

Clinical outcome and molecular landscape of patients with ARID1A‐loss gastric cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2906772169

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2906772169

Other Identifiers

ISSN

1347-9032

E-ISSN

1349-7006

DOI

10.1111/cas.16057

How to access this item